SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is trending as the community rallies behind the token, fueled by speculation that it's connected to xAI and Elon Musk. Community members are actively discussing its potential as 'Grok's pup' and highlighting its strong community, while also cautioning about fake Solana versions.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending due to a significant drop following mixed results from a Phase 3 trial, leading to community discussion about the severity of the reaction and potential manipulation. Despite the setback, some believe the stock is oversold, citing the company's diverse pipeline and cash runway, while others worry about the drug's market viability. The steep decline has triggered speculation about a potential buyout and the possibility of a sharp rebound.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a crypto focused on culture, freedom, and community, aiming to bridge the cannabis industry with Web3. Bullish sentiment seems to be growing, with some users highlighting potential catalysts such as possible shifts in cannabis legalization and touting community growth.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a sharp decline following a LinkedIn post by a former FDA official questioning the safety and efficacy of its drug, voclosporin. The community is discussing the motives behind the post, potential conflicts of interest, and the company's response, with some speculating about market manipulation and calling for legal action. Despite a partial recovery, the incident has shaken investor confidence, raising broader concerns about leadership and future prospects.

Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Applied Dna Sciences Inc

APDN is trending due to a recently announced private placement intending to initiate a BNB-focused digital asset strategy, including a potential ticker change to BNBX. The community is actively discussing the implications of this shift away from their DNA technology, comparing it to similar crypto treasury plays, and speculating on potential price movements. Some traders are wary of dilution and potential scams, while others see it as a high-potential opportunity given the company's low float.

Akira Labs builds tools to enhance users’ trading experience across multiple blockchains. Our Telegram-based bot allows automated trades, real-time copy trading, and whale tracking, giving traders speed, transparency, and actionable insights. We aim to create a complete ecosystem where users can track markets, make informed decisions, and participate in exclusive products available only to token holders. “Empowering traders"

AKIRA LABS

AKIRA.X is trending alongside other tokens like WAGMI.X and SOL.X, with many users adding it to their watchlists. The community seems to be discussing potential for big moves and are optimistic about a potential meme cycle. Some users are calling it a gem.

American Exceptionalism Acquisition Corp. A is a blank check company. It was created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on July 11, 2025 and is headquartered in Menlo Park, CA.

American Exceptionalism Acquisition Corp. A - Ordinary Shares - Class A

American Exceptionalism Acquisition Corp. A

American Exceptionalism Acquisition Corp. A ($AEXA) is trending as traders speculate about a potential acquisition target, with some suggesting names like Polymarket or even Elon Musk's Starlink. The community is showing excitement reminiscent of past SPAC booms and anticipating potential gains, while also expressing both support and distrust for Chamath Palihapitiya's involvement.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Despite positive catalysts like potential rate cuts, Upstart is trending downwards, leading to community frustration and speculation about manipulation or underlying issues such as rising delinquencies; short interest is high. The community is closely watching key support levels, while debating whether the dip presents a buying opportunity or signals further decline amid broader fintech sector concerns.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis ($ACB) is trending as cannabis stocks react to potential rescheduling catalysts, including Trump's comments regarding medical applications of CBD. Community discussions focus on the stock's technical setup, potential for a short squeeze given the relatively low share count, and comparisons to sector peers like $TLRY and $CGC. Some investors express optimism about the company's financials and strategic positioning in the medical cannabis market, while others remain cautious, citing historical volatility.

Gremly

Gremly ($GREMLY.X) is gaining attention as the community discusses its potential and compares it to other meme coins. Some are urging broader promotion of the token, while others emphasize a long-term investment perspective. The token is also being mentioned alongside other trending cryptos, such as $UPDOG.X and $SHIB.X.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Warner Bros. Discovery stock falls after Advance/Newhouse sells $1B stake

Investing.com -- Warner Bros. Discovery (NASDAQ:WBD) stock declined 4.9% Tuesday, falling from $11.46 to $10.90 after major shareholder Advance/Newhouse sold over $1 billion in shares.

Warner Bros. Discovery to split into two media companies

Investing.com -- Warner Bros. Discovery (NASDAQ: NASDAQ:WBD) shares paused trading on Monday pending a significant announcement. The company revealed plans to separate into two leading media corporations.

BT set to sell TNT Sports stake to Warner Bros Discovery – FT

Warner Bros, Arm and Peloton fall premarket;  Tapestry, Kenvue rise

Investing.com -- U.S. stock futures rose strongly Thursday on hopes that a trade deal between the U.S. and the U.K., as well as talks could reduce uncertainty surrounding global trade policies. 

MoffettNathanson sees more downside risk for media and internet stocks

Investing.com -- A sudden shift in U.S. trade policy has sharply darkened the economic outlook, with MoffettNathanson now warning that sweeping new tariffs could push the country into recession and erase $45 billion in expected ad spending in 2025. Though Trump said authorized a 90-day pause on "reciprocal" and 10% tariffs, effective immediately.

Deutsche Bank downgrades Paramount Global, cuts target on dour outlook

Investing.com -- Deutsche Bank downgraded Paramount Global to "Hold" from "Buy" on Tuesday, citing lower earnings expectations and rising risks to the advertising outlook, while also reducing its price target to $12 from $15.

Warner Bros jumps on streaming profits guide, encouraging studios, D2C results

Investing.com -- Warner Bros. Discovery (NASDAQ:WBD) said on Thursday it expects its streaming profits to double in 2025 and is projecting at least 150 million subscribers by 2026.

Warner Bros. Discovery misses top and bottom line estimates in Q4

Investing.com -- Warner Bros. Discovery (NASDAQ:WBD) reported fourth-quarter earnings and revenue that fell short of analyst expectations.

MoffettNathanson upgrades Warner Bros Discovery, downgrades Fox Corp

Investing.com -- MoffettNathanson upgraded Warner Bros Discovery Inc (NASDAQ:WBD) to "Buy" from "Neutral," citing improved financial stability, growth at Max, and easing studio challenges.

Will M&A really be a way out for media companies in 2025?

Investing.com -- While there are expectations of mergers and acquisitions (M&A) in the U.S. media industry in 2025,  Barclays  (LON:BARC) analysts suggest that only a few strategic transactions may truly make sense. 

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros.Discovery Inc - Ordinary Shares - Class B

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

DISCB
Discovery Communications, Inc

Feed

News

Sentiment

Fundamentals

Info

Latest DISCB News

DISCB Discovery Communications, Inc